DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

108.26 0.48 (0.45%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LGND $108.26 0.45%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $108.04
Previous Close $107.78
Daily Range $106.67 - $109.58
52-Week Range $41.99 - $109.95
Market Cap $2.1B
P/E Ratio 215.56
Dividend (Yield) $0.00 (0.0%)
Volume 342,625
Average Daily Volume 380,701
Current FY EPS $2.82

Sector

Healthcare

Industry

Drug Makers

Ligand Pharmaceuticals, Inc. (LGND) Description

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases. Website: http://www.ligand.com/

News & Commentary Rss Feed

3 Biotech Stocks With Incredible Growth Prospects

If you're looking for market-crushing growth, the healthcare contributors we spoke to would recommend these three biotech stocks!

Acorda 2Q Earnings & Revenues Top, Ampyra in Focus - Analyst Blog

QLT (QLTI) Reports Wider-than-Expected Loss in Q2 - Analyst Blog

Theravance's Q2 Loss Wider-than-Expected, Revenues Miss - Analyst Blog

Alexion Misses on Earnings in Q2, 2015 Outlook Revised - Analyst Blog

Hospira (HSP) Beats on Q2 Earnings Driven by Strong Sales - Analyst Blog

United Therapeutics Misses on Q2 Earnings & Revenues - Analyst Blog

Longs Vs. Shorts In Ligand Pharma: Roth Capital Analyst Squares Up Against Hedge Fund

The Zacks Analyst Blog Highlights: Biogen, Ligand Pharmaceuticals, bluebird bio, Regeneron Pharmaceu

The Zacks Analyst Blog Highlights: Biogen, Ligand Pharmaceuticals, bluebird bio, Regeneron Pharmaceuticals and Exelixis - Press Releases

Biogen Tops Q2 Earnings, Cuts View on Tecfidera Issues - Analyst Blog

Biogen Tops Q2 Earnings, Cuts View on Tecfidera Issues - Analyst Blog

AbbVie Tops Earnings, Misses on Revenues, Maintains View - Analyst Blog

See More LGND News...

LGND's Top Competitors

LGND $108.26 (0.45%)
Current stock: LGND
AMGN $176.59 (2.85%)
Current stock: AMGN
CELG $131.25 (-0.48%)
Current stock: CELG
GILD $117.86 (-0.03%)
Current stock: GILD